Histogen
Home > About Histogen > Board

Board of Directors
Gail K. Naughton, Ph.D., Chairman of the Board

Gail K. NaughtonDr. Naughton has been the Dean of the College of Business Administration at San Diego State University since August 2002. Prior to that, she spent more than 15 years at Advanced Tissue Sciences, where she was the company's co-founder and co-inventor of its core technology. During her tenure there, Dr. Naughton held a variety of key management positions, including president, chief operating officer, chief scientific officer and principal scientist. gnaughton@histogeninc.com

Dr. Stephen Chang

Dr. Stephen ChangDr. Chang has served as a director of the Multicell Technologies since June 2004, became president of the Multicell Technologies in February 2005, and was appointed chief executive officer (CEO) in May 2006. Dr. Chang is also president of MCT Rhode Island Corp. and Xenogenics Corporation, and president, chief financial officer (CFO), treasurer, and director of MCTI, a partially-owned subsidiary of the Company.


Dr. Stephen Badylak, Director of the Board, Chair, Scientific Advisory Board

Dr. Stephen BadylakDr. Badylak is a Professor in the Department of Surgery, a deputy director of the McGowan Institute for Regenerative Medicine (MIRM), and Director of the Center for Pre-Clinical Tissue Engineering within the Institute. In 1976, Dr. Badylak received his D.V.M. from Purdue University. He then obtained an M.S. in Clinical Pathology from Purdue University in 1978, a Ph.D. in Anatomic Pathology from Purdue University in 1981 and graduated with highest honors with a M.D. from Indiana University Medical School in 1985.

Leonard H. Lavin, Founder & Chairman Emeritus, Alberto-Culver Company

Leonard H. LavinLeonard H. Lavin is the founder, Chairman Emeritus and a director of the Alberto-Culver Company (NYSE: ACV), a $1.4 billion company which manufactures, markets and distributes beauty, personal care and household/ grocery products in over 120 countries. Alberto-Culver's leading global personal care products include Alberto VO5, TRESemme, St. Ives, Nexxus, Soft & Beautiful, Motions and Just For Me and a group of important regional brands.

John Rao, Founder & CEO, Secure Medical Inc.

John RaoMr. Rao's passion for technology spans over 40 years including many patents and patent applications. Currently, he is the founder and CEO of Secure Medical, Inc., a medical technology company based in Tempe, Arizona. He was awarded degrees in both science and technology from accredited Universities and institutes in Canada. Mr. Rao has owned and operated 14 technology driven companies in retail, wholesale, manufacturing and product development industries as well as computer sciences and security driven methodologies.

Scientific Advisory Board

Craig L. Ziering, D.O., FAOCD

Craig L. ZieringDr. Craig L. Ziering is a leading authority in hair transplant surgery, with more than 16 years of specialized experience in hair restoration. In addition to performing over 12,000 hair transplant procedures, he is an author, lecturer, trusted surgeon to physicians, and innovator in the field. As founder and medical director of Ziering Medical, he currently operates hair restoration centers throughout California, Utah and Nevada.


Lawrence A. Rheins, PhD

Lawrence A. RheinsDr. Rheins is currently Vice President of Science and Technology at Floratech International, a raw material supplier of botanical derived ingredients for the cosmetic and personal care industries. In 1996, he founded DermTech International, a contract research organization, biotechnology company focused on cosmetics and dermatologic diagnostics and served as the company's CEO until 1999. Thereafter, he served as Executive Vice President until DermTech's clinical operations were sold in 2004.

Dale P. DeVore, Ph.D.

Dale P. DeVore

Dale Devore is currently Vice President of Research & Development for BioForm Medical, Inc. Prior to joining BioForm, he was a consultant to several major medical device companies, including three involved in developing dermal filler products. He was previously a member of the Board of Directors and Senior Vice President of Research & Development and the Chief Scientific Officer for Collagenesis, Inc., and inventor/ co-inventor of all of the Company's technologies.

Histogen Inc. is a regenerative medicine company based on the commercialization of products manufactured by newborn human fibroblasts.
  • Broad range of markets, which are underserved and expected to grow
  • Rich product portfolio
  • Solutions without the use of embryonic stem cells or animal products
© Histogen Inc., CA 92101